berbamine has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, Y; Jiao, Y; Ren, Y; Shi, C; Shi, X; Song, X; Zhang, H | 1 |
1 other study(ies) available for berbamine and Ovarian Neoplasms
Article | Year |
---|---|
Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Benzylisoquinolines; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Ovarian Neoplasms; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2018 |